Company news
Solvonis Therapeutics PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
New R&D and Supply Agreement with Gabriel Chemie
July 6, 2023
Operational Update
July 5, 2023
AGM Notice
July 4, 2023
Director Share Purchase
May 16, 2023
Final Results
April 27, 2023
GraftBio - MGC Pharma Update
March 21, 2023
Corporate Presentation
March 20, 2023
Update: New Product Lines & Facility Expansion
February 9, 2023
Interim Results
September 30, 2022
New Corporate Presentation
September 20, 2022
First Commercial Purchase Order for GraftBio
August 18, 2022
GraftBio IP - MGC Pharma Update
June 17, 2022
HACCP Certificate Enabling Access to B2C Market
May 12, 2022
Grant of patents
April 22, 2022
Pre-payment for equipment
April 7, 2022
Director/PDMR Shareholding
April 6, 2022
Update on Operations
February 21, 2022
Change of Year End
February 15, 2022
Admission to Main Market, First Day of Dealings
January 6, 2022
Decks
- Investor Presentation (October 2026)
Investor deck · 38 slides · Oct 13, 2026
- Investor Presentation (October 2026)
Investor deck · 37 slides · Oct 13, 2026
- Investor Presentation (September 2026)
Investor deck · 26 slides · September 2026